CH400138A - Verfahren zur Herstellung von 13-Methylverbindungen der 5a- oder 5B-D-Homoandrostan- bzw. der 19-Nor-1,3,5(10)-pregnatrienreihe - Google Patents

Verfahren zur Herstellung von 13-Methylverbindungen der 5a- oder 5B-D-Homoandrostan- bzw. der 19-Nor-1,3,5(10)-pregnatrienreihe

Info

Publication number
CH400138A
CH400138A CH377261A CH377261A CH400138A CH 400138 A CH400138 A CH 400138A CH 377261 A CH377261 A CH 377261A CH 377261 A CH377261 A CH 377261A CH 400138 A CH400138 A CH 400138A
Authority
CH
Switzerland
Prior art keywords
homoandrostane
pregnatriene
series
preparation
methyl compounds
Prior art date
Application number
CH377261A
Other languages
English (en)
Inventor
Nagata Wataru
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of CH400138A publication Critical patent/CH400138A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/44—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed ring system having more than three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/18—Saturated compounds containing keto groups
    • C07C62/26—Saturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/40—Ortho- or ortho- and peri-condensed systems containing four condensed rings
    • C07C2603/42—Ortho- or ortho- and peri-condensed systems containing four condensed rings containing only six-membered rings
    • C07C2603/48—Chrysenes; Hydrogenated chrysenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH377261A 1960-03-12 1961-03-29 Verfahren zur Herstellung von 13-Methylverbindungen der 5a- oder 5B-D-Homoandrostan- bzw. der 19-Nor-1,3,5(10)-pregnatrienreihe CH400138A (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP820860 1960-03-12
JP942160 1960-03-19
JP2012560 1960-04-04
JP2012460 1960-04-04
JP2072360 1960-04-06
JP2241760 1960-04-21
JP2261160 1960-04-25
JP2598661 1961-07-19

Publications (1)

Publication Number Publication Date
CH400138A true CH400138A (de) 1965-10-15

Family

ID=27571631

Family Applications (6)

Application Number Title Priority Date Filing Date
CH278661A CH416602A (de) 1960-03-12 1961-03-08 Verfahren zur selektiven Einführung einer Cyan-Gruppe in eine Winkelstellung eines Polyhydronaphthalins, Polyhydrophenanthrens, Polyhydrochrysens oder Steroides
CH323761A CH419113A (de) 1960-03-12 1961-03-17 Verfahren zur Herstellung von D-Homo-androstan-18-säuren
CH329266A CH430707A (de) 1960-03-12 1961-03-17 Verfahren zur Herstellung von 18-Oxoverbindungen der 5a- oder 5B-D-Homoandrostan-Reihe bzw. der 19-Nor-1,3,5(10)-pregnatrienreihe
CH377261A CH400138A (de) 1960-03-12 1961-03-29 Verfahren zur Herstellung von 13-Methylverbindungen der 5a- oder 5B-D-Homoandrostan- bzw. der 19-Nor-1,3,5(10)-pregnatrienreihe
CH478061A CH406202A (de) 1960-03-12 1961-04-24 Verfahren zur Herstellung von 3-substituierten D-Homo-18-nor-androst-13-(17a)-en-17-on-derivaten
CH871762A CH491886A (de) 1960-03-12 1962-07-19 Verfahren zur Herstellung eines Pregnadiens

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CH278661A CH416602A (de) 1960-03-12 1961-03-08 Verfahren zur selektiven Einführung einer Cyan-Gruppe in eine Winkelstellung eines Polyhydronaphthalins, Polyhydrophenanthrens, Polyhydrochrysens oder Steroides
CH323761A CH419113A (de) 1960-03-12 1961-03-17 Verfahren zur Herstellung von D-Homo-androstan-18-säuren
CH329266A CH430707A (de) 1960-03-12 1961-03-17 Verfahren zur Herstellung von 18-Oxoverbindungen der 5a- oder 5B-D-Homoandrostan-Reihe bzw. der 19-Nor-1,3,5(10)-pregnatrienreihe

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH478061A CH406202A (de) 1960-03-12 1961-04-24 Verfahren zur Herstellung von 3-substituierten D-Homo-18-nor-androst-13-(17a)-en-17-on-derivaten
CH871762A CH491886A (de) 1960-03-12 1962-07-19 Verfahren zur Herstellung eines Pregnadiens

Country Status (7)

Country Link
US (4) US3206472A (de)
CH (6) CH416602A (de)
DE (5) DE1234714B (de)
DK (1) DK113427B (de)
FR (1) FR1517665A (de)
GB (9) GB915892A (de)
NL (2) NL6512737A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL113064C (de) * 1960-03-12
US3294817A (en) * 1964-03-23 1966-12-27 American Home Prod Octahydroindolobenzazepines and compounds intermediate thereto
US3835160A (en) * 1967-06-06 1974-09-10 Schering Corp 3{40 -keto-2{40 ,3{40 -seco-1{40 -(2{40 )-yne steroidal derivatives, methods for their manufacture, and compounds produced thereby
US3898264A (en) * 1970-08-26 1975-08-05 Hoffmann La Roche Steroid total synthesis process utilizing a cyanoalkyl A-ring precursor
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US5480913A (en) * 1989-09-27 1996-01-02 Arch Development Corporation Anti-androgen compounds
US5116865A (en) * 1990-09-05 1992-05-26 Peters Richard H 15,16-seco-19-nor progestins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3024271A (en) * 1958-08-08 1962-03-06 Lab Francais Chimiotherapie 3, 11, 17-trioxygenated-18-nor-d-homo-13alpha-steroids and processes for their preparation
NL113064C (de) * 1960-03-12

Also Published As

Publication number Publication date
NL6512737A (de) 1965-12-27
FR1517665A (fr) 1968-03-22
GB915892A (en) 1963-01-16
CH416602A (de) 1966-07-15
DE1260466B (de) 1968-02-08
US3403167A (en) 1968-09-24
GB959798A (en) 1964-06-03
GB984022A (en) 1965-02-24
DE1593385A1 (de) 1971-03-25
CH406202A (de) 1966-01-31
GB945518A (en) 1964-01-02
CH430707A (de) 1967-02-28
DE1203262B (de) 1965-10-21
CH491886A (de) 1970-06-15
US3206472A (en) 1965-09-14
GB984021A (en) 1965-02-24
CH419113A (de) 1966-08-31
DK113427B (da) 1969-03-24
US3197485A (en) 1965-07-27
DE1172670B (de) 1964-06-25
DE1191808B (de) 1965-04-29
GB936892A (en) 1963-09-18
GB959799A (en) 1964-06-03
DE1234714B (de) 1967-02-23
US3407212A (en) 1968-10-22
GB984023A (en) 1965-02-24
NL113064C (de)
GB984024A (en) 1965-02-24

Similar Documents

Publication Publication Date Title
CH402846A (de) Verfahren zur Herstellung von 19-Nor-4,9(10)-Steroiden
CH423799A (de) Verfahren zur Herstellung von 3,8-Diazabicyclo-(3,2,1)-oktanen
CH457473A (de) Verfahren zur Herstellung von 9,10-Dihydroergovalin
CH390924A (de) Verfahren zur Herstellung von 1,3,4-Thiadiazolen
CH384750A (de) Verfahren zur Herstellung von neuen 2,3 : 6,7-Diareno-1-oxa-4,5-diazepinen
CH400138A (de) Verfahren zur Herstellung von 13-Methylverbindungen der 5a- oder 5B-D-Homoandrostan- bzw. der 19-Nor-1,3,5(10)-pregnatrienreihe
CH397704A (de) Verfahren zur Herstellung von 4-Oxo-1,2,3,4-tetrahydro-chinazolinen
CH398622A (de) Verfahren zur Herstellung von 2,4-Bis-amino-6-trichlormethyl-s-triazinen
CH405326A (de) Verfahren zur Herstellung von 1,3-Diaryl-pyrazolinen
CH403777A (de) Verfahren zur Herstellung von 2,5-substituierten Thiophenderivaten
AT245580B (de) Verfahren zur Herstellung von 1,6-Dibrom-1,6-didesozy-D-mannit
AT238198B (de) Verfahren zur Herstellung von 1, 3, 5-Trioxan
CH424758A (de) Verfahren zur Herstellung von 2,6-Dichlorbenzaldoxim
CH441304A (de) Verfahren zur Herstellung von 3-Hydroxy- bzw. 3-Alkoxy-, 3-Aralkoxy- oder 3-Cycloalkoxy-1,3,5(10)-östratrienen
CH404678A (de) Verfahren zur Herstellung von neuen 3,8-Diazabicyclo-(3,2,1)-octanen
CH407989A (de) Verfahren zur Herstellung von 2,2-Dihalogencyclopropancarbonsäuren
CH388969A (de) Verfahren zur Herstellung von 4,4'-Methenyl-bis-(pyrazolonen-(5))
AT240863B (de) Verfahren zur Herstellung von neuen 2-Acyl-hydrazino-4,6-bis-tert.-amino-1,3,5-triazinen
CH442306A (de) Verfahren zur Herstellung von 3,4-Dihydro-benzoxazinonen-(1,3,2)
CH428763A (de) Verfahren zur Herstellung von Enhalogeniden von Grisantrion-(3,2',4')
CH412905A (de) Verfahren zur Herstellung von cycloalkylierten 2,3-Dihydro-1,4-benzthiazinen
CH400170A (de) Verfahren zur Herstellung von 3,5-Pyrazolidindionderivaten
CH432487A (de) Verfahren zur Herstellung von Mononitro-1,3,5-trialkylbenzol
AT226660B (de) Verfahren zur Herstellung von 2,3-Dibrom- oder 2-Brom-3-chlor-propen-1
AT217468B (de) Verfahren zur Herstellung von 2-Thion-4,4,6-trimethyl-tetrahydropyrimidin